painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain

@article{Freynhagen2006painDETECTAN,
  title={painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain},
  author={Rainer Freynhagen and Ralf Baron and Ulrich Gockel and Thomas R. T{\"o}lle},
  journal={Current Medical Research and Opinion},
  year={2006},
  volume={22},
  pages={1911 - 1920}
}
OBJECTIVE Nociceptive and neuropathic components both contribute to pain. [] Key MethodMETHODS In co-operation with the German Research Network on Neuropathic Pain we developed and validated the painDETECT questionnaire (PD-Q) in a prospective, multicentre study and subsequently applied it to approximately 8000 LBP patients.
View on Taylor & Francis
ncbi.nlm.nih.gov
1,490 Citations
Highly Influential Citations
101
Background Citations
345
Methods Citations
273
Results Citations
26

1,490 Citations

Citation Type

Citation Type

Correlation between the Neuropathic PainDETECT Screening Questionnaire and Pain Intensity in Chronic Pain Patients
TLDR
The findings of the questionnaire suggest that a significant proportion of chronic pain patients had manifested features of NP at the first visit to the outpatient clinic, suggesting that the PD-Q is a useful screening tool to alert clinicians of NP that may need further diagnostic evaluation or therapeutic intervention and may also help to predict treatment response.
Evaluation of the Neuropathic Component of Chronic Low Back Pain
TLDR
Using a cut-off value of 19, PDQ identified a neuropathic component in a relatively low proportion of patients with CRS, and QST reveals sensory loss as a frequent abnormality in patients withCRS.
Identifying neuropathic back and leg pain: a cross-sectional study
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain
TLDR
Assessing the consistence and discrepancy of two widely used screening tools, The Douleur Neuropathique 4 (DN4) and the 6-item questionnaire (ID-Pain), by comparing their ability in discriminating neuropathic from nociceptive pain found them to be highly interrelated in the identification of neuropathic pain.
Axial Low Back Pain: One Painful Area – Many Perceptions and Mechanisms
TLDR
From data used to estimate whether neuropathic pain contributes to axial low back pain and if so to what extent, sensory profiles based on descriptor severity may serve as a better predictor for therapy assessment than pain intensity or sole diagnosis alone.
Short Screening for the Presence of Neuropathic Pain Component - What the Clinical Nurses Need to Know
TLDR
A screening for the presence of neuropathy pain is an important element in the management of cancer pain and nurses should know the contribution of neuropathic pain in cancer pain in clinical practi ce.
Detecting the neuropathic pain component in the clinical setting: a study protocol for validation of screening instruments for the presence of a neuropathic pain component
TLDR
The aim of this study is to validate the Dutch language versions of the PainDETECT Questionnaire and the ‘Douleur Neuropathique 4 Questions’ (DN4-Dlv) for use in primary and specialist medical care settings to screen for a NePC in patients with chronic pain.
Psychological factors can cause false pain classification on painDETECT
TLDR
Psychological factors including catastrophizing, depression, anxiety, and stress were all influential in producing a higher score on the PD-Q and a high rate of false positive NeP classification was observed which was associated with the presence of anxiety.
Prevalence of Neuropathic Pain Symptoms in Foot and Ankle Patients
TLDR
A considerable number of patients with foot and ankle problems requiring surgery had a neuropathic component of pain, and evaluation of their risk factors and level of pain may help with the diagnosis, decision making, and pain control.
Avoiding Catch-22: validating the PainDETECT in a in a population of patients with chronic pain
TLDR
Despite its internal consistency and test-retest reliability the PainDETECT-Dlv is not an effective screening tool for a neuropathic pain component in a population of patients with chronic pain because of its moderate sensitivity and low specificity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
Symptoms and signs in patients with suspected neuropathic pain
Development of a Neuropathic Pain Questionnaire
TLDR
The development of an assessment instrument intended to measure neuropathic pain based on qualities of pain as they are inferred from pain descriptors is described, which has the ability to provide a quantitative measure for the descriptors important in the diagnosis and assessment of neuropathicPain.
The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
[How neuropathic is sciatica? The mixed pain concept].
TLDR
The combination of these analgesic compounds with NSAID could be useful in patients with sciatic pain who do not respond to NSAID, i.e., antidepressants such as amitriptyline and anticonvulsants such as gabapentin, carbamazepine, and pregabalin.
EFNS guidelines on neuropathic pain assessment
TLDR
This review led to the development of guidelines to be used in the management of patients with neuropathic pain, and the simplest psychometric scales and quality of life measures are probably the best methods.
Diagnosis and classification of chronic low back pain disorders: maladaptive movement and motor control impairments as underlying mechanism.
Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints
Algorithm for neuropathic pain treatment : An evidence based proposal
TLDR
NNT and NNH are currently the best way to assess relative efficacy and safety, but the need for dichotomous data, which may have to be estimated retrospectively for old trials, and the methodological complexity of pooling data from small cross-over and large parallel group trials, remain as limitations.
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
TLDR
Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain.
...
1
2
3
...